60 Percent of Childhood Hearing Loss Preventable
A new review highlights the underrecognized potential of vaccines to prevent childhood hearing loss, especially in low- and middle-income countries.
A new review highlights the underrecognized potential of vaccines to prevent childhood hearing loss, especially in low- and middle-income countries.
Cilcare raised €40 million in Series A funding to initiate two clinical trials in 2025 for treatment of cochlear synaptopathy.
A national poll by ASHA reveals that a majority of adults with communication disorders experience significant stigmas.
When a COVID-19 survivor reports that they have been diagnosed with brain fog or mild cognitive impairment (BF/MCI), or these terms appear in a medical report, hearing care professionals should be aware that many of the BF/MCI symptoms are very similar to those seen in patients with (central) auditory processing disorder. This article by audiologist Robert DiSogra, AuD, reviews the research on this subject and provides recommendations.
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
Akouos, Inc announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) issued a positive opinion on the company’s application for orphan drug designation for AK-OTOF, a gene therapy intended for the treatment of otoferlin gene-mediated hearing loss. The positive opinion was subsequently adopted by the European Commission.
A new product designed to treat eardrum perforations developed by a Harvard doctoral student, Nicole Black, has just won the “Cure It!” Lemelson-MIT Student Prize.